Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Molecules ; 26(16)2021 Aug 22.
Article in English | MEDLINE | ID: mdl-34443670

ABSTRACT

Enterococci and methicillin-resistant S. aureus (MRSA) are among the menacing bacterial pathogens. Novel antibiotics are urgently needed to tackle these antibiotic-resistant bacterial infections. This article reports the design, synthesis, and antimicrobial studies of 30 novel pyrazole derivatives. Most of the synthesized compounds are potent growth inhibitors of planktonic Gram-positive bacteria with minimum inhibitory concertation (MIC) values as low as 0.25 µg/mL. Further studies led to the discovery of several lead compounds, which are bactericidal and potent against MRSA persisters. Compounds 11, 28, and 29 are potent against S. aureus biofilms with minimum biofilm eradication concentration (MBEC) values as low as 1 µg/mL.


Subject(s)
Bacteria/growth & development , Drug Resistance, Bacterial/drug effects , Growth Inhibitors/chemical synthesis , Growth Inhibitors/pharmacology , Pyrazoles/chemical synthesis , Pyrazoles/pharmacology , Bacteria/drug effects , Biofilms/drug effects , Cell Death/drug effects , Enterococcus faecalis/drug effects , Enterococcus faecalis/physiology , Growth Inhibitors/chemistry , HEK293 Cells , Humans , Methicillin-Resistant Staphylococcus aureus/drug effects , Methicillin-Resistant Staphylococcus aureus/physiology , Microbial Sensitivity Tests , Pyrazoles/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...